Rare lung cancer: gene activation determines mild or aggressive course
Pulmonary carcinoids are rare tumours of the lung with extremely different clinical courses. In many…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Medical researchers earn grants for innovative approaches to breast cancer
As Breast Cancer Awareness Month begins, two College of Medicine cancer researchers have received statewide grants to…
Scientist develops new model for ovarian cancer – with crossover to uterine cancer
Most uterine cancers have excellent five-year survival rates – up to 95% for localised cancer.…
One million people who never regularly smoked now vape in England
The number of adults vaping in England who have never regularly smoked has increased sharply…
FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer
On October 3, 2024, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb…
Epigenetic hallmarks that define cancer
Cancer mortality has just surpassed cardiovascular disease for the first time and one in two…
The Lancet Public Health: Banning tobacco sales among young people could prevent 1.2 million lung cancer deaths, global modelling study suggests
Creating a generation of people who never smoke could prevent 1.2 million deaths from lung…
Faster, more sensitive lung cancer detection from a blood draw
A new way of diagnosing lung cancer with a blood draw is 10 times faster…
New imaging technique accurately detects aggressive kidney cancer
A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Centre, USA, has demonstrated…
Team engineers new enzyme to produce synthetic genetic material
A research team led by the University of California, Irvine, USA, has engineered an efficient…